Facets (new session)
Description
Metadata
Settings
owl:sameAs
Inference Rule:
b3s
b3sifp
dbprdf-label
facets
http://dbpedia.org/resource/inference/rules/dbpedia#
http://dbpedia.org/resource/inference/rules/opencyc#
http://dbpedia.org/resource/inference/rules/umbel#
http://dbpedia.org/resource/inference/rules/yago#
http://dbpedia.org/schema/property_rules#
http://www.ontologyportal.org/inference/rules/SUMO#
http://www.ontologyportal.org/inference/rules/WordNet#
http://www.w3.org/2002/07/owl#
ldp
oplweb
skos-trans
virtrdf-label
None
About:
Clinical Characteristics of Re‐hospitalized Patients with COVID‐19 in China
Goto
Sponge
NotDistinct
Permalink
An Entity of Type :
schema:ScholarlyArticle
, within Data Space :
wasabi.inria.fr
associated with source
document(s)
Type:
Academic Article
research paper
schema:ScholarlyArticle
New Facet based on Instances of this Class
Attributes
Values
type
Academic Article
research paper
schema:ScholarlyArticle
isDefinedBy
Covid-on-the-Web dataset
title
Clinical Characteristics of Re‐hospitalized Patients with COVID‐19 in China
Creator
Wei, Wei
Chen, Min
Zhang, Jianjun
Qin, Tao
Zhou, Qin
Liu, Jialin
Xu, ;
Zhang, ;
Yang, ;
Xia, Fei
An, Wei
Fang, Shasha
Fei Xia, ;
Li, Kuangyu
Liao, Yaling
Liu, Shiguo
Zhang, Guowei
Zhang, Mingwei
Zhang, Yafang
source
Medline; PMC
abstract
BACKGROUND: This study aims to observe the clinical characteristics of recovered patients from Coronavirus Disease 2019 (COVID 19) with positive in RT‐PCR or serum antibody. METHODS: The profile, clinical symptoms, laboratory outcomes and radiologic assessments were extracted on 11 patients, who tested positive for COVID‐19 with RT‐PCR or serum antibody after discharged and was admitted to Hubei No. 3 People's Hospital of Jianghan University for a second treatment in March 2020. RESULTS: The average interval time between the first discharge and the second admission measured 16.00 ± 7.14 days, ranging from 6 to 27 days. In the second hospitalization, 1 patient was positive for RT‐PCR and serum antibody IgM‐IgG, 5 patients were positive for both IgM and IgG but negative for RT‐PCR. 3 patients were positive for both RT‐PCR and IgG but negative for IgM. The main symptoms were cough (54.5%), fever (27.3%) and feeble (27.3%) in the second hospitalization. Compared with the first hospitalization, there were significant decreases in gastrointestinal symptoms (5 vs. 0, P=0.035), elevated levels of both white blood cell count(P=0.036) and lymphocyte count (P=0.002), remarkedly decreases in CRP and SAA (P<0.05) in the second hospitalization. Additionally, 6 patients' chest CT exhibited notable improvements in acute exudative lesions CONCLUSION: There could be the positive results for RT‐PCR analysis or serum IgM‐IgG in discharged patients, even with mild clinical symptoms, however, their laboratory outcomes and chest CT images would not indicate the on‐going development in those patients. This article is protected by copyright. All rights reserved.
has issue date
2020-05-13
(
xsd:dateTime
)
bibo:doi
10.1002/jmv.26002
bibo:pmid
32401361
has license
no-cc
sha1sum (hex)
1038d500226cb002140588032adeaccbf6db8497
schema:url
https://doi.org/10.1002/jmv.26002
resource representing a document's title
Clinical Characteristics of Re‐hospitalized Patients with COVID‐19 in China
has PubMed Central identifier
PMC7272928
has PubMed identifier
32401361
schema:publication
J Med Virol
resource representing a document's body
covid:1038d500226cb002140588032adeaccbf6db8497#body_text
is
schema:about
of
named entity 'COVID-19'
named entity 'COVID-19'
named entity 'RT-PCR'
named entity '8 days'
named entity 'Wuhan'
named entity 'RT-PCR'
named entity 'RT-PCR'
named entity 'infection'
named entity 'clinical symptoms'
named entity 'infectious disease'
named entity 'interquartile range'
named entity 'RT-PCR test'
named entity 'intensive care unit'
named entity 'IgG'
named entity 'RT-PCR'
named entity 'Min Chen'
named entity 'Multidisciplinary'
named entity 'research and development'
named entity 'antibody'
named entity 'RT-PCR'
named entity 'COVID-19'
named entity 'serum'
named entity 'IgG'
named entity 'inflammatory response'
named entity 'prognosis'
named entity 'RT-PCR'
named entity 'IgG'
named entity 'virus'
named entity 'liver'
named entity 'positive outcomes'
named entity 'RT-PCR'
named entity 'fever'
named entity 'infection'
named entity 'asymptomatic'
named entity 'pneumonia'
named entity 'RT-PCR'
named entity 'erythrocyte sedimentation rate'
named entity 'throat swab'
named entity 'longitudinal studies'
named entity 'IgG'
named entity 'fever'
named entity 'respiratory medicine'
named entity 'COVID-19'
named entity 'diabetes'
named entity 'sputum'
named entity 'biochemical'
named entity 'RT-PCR'
named entity 'IgM'
named entity 'epidemic'
named entity 'electronic medical records'
named entity 'cough'
named entity 'IgG'
named entity 'antibody'
named entity 'IgG'
named entity 'gastrointestinal symptoms'
named entity 'white blood cell count'
named entity 'virus'
named entity 'IgM'
named entity 'IgG'
named entity 'gastrointestinal symptoms'
named entity 'COVID-19'
named entity 'severe acute respiratory syndrome coronavirus 2'
named entity 'nausea'
◂◂ First
◂ Prev
Next ▸
Last ▸▸
Page 1 of 4
Go
Faceted Search & Find service v1.13.91 as of Mar 24 2020
Alternative Linked Data Documents:
Sponger
|
ODE
Content Formats:
RDF
ODATA
Microdata
About
OpenLink Virtuoso
version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software